EP3639828
NOTKUN OXAÐRA KÓLESTERÓLSÚLFATA (OKS) Í MEÐFERÐ VIÐ BRÁÐRI LIFRARBILUN
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
23.12.2014EP published:
1.12.2021EP application number:
19214560.5
EP translation filed:
4.2.2022Grant published:
15.4.2022EPO information:
European Patent Register
Max expiry date:
22.12.2034Expiry date:
22.12.2024
Title in English:
USE OF OXYGENATED CHOLESTEROL SULFATES (OCS) FOR TREATING ACUTE LIVER FAILURELanguage of the patent:
English
Timeline
Today
23.12.2014EP application
1.12.2021EP Publication
4.2.2022Translation submitted
15.4.2022Registration published
22.12.2024Expires
Owner
Name:
Virginia Commonwealth UniversityAddress:
800 East Leigh Street Suite 3000, Richmond, VA 23298, US
Name:
Durect CorporationAddress:
10240 Bubb Road, Cupertino, CA 95014-4166, US
Inventor
Name:
REN, ShunlinAddress:
Richmond, VA Virginia 23249, US
Name:
THEEUWES, FelixAddress:
Los Altos Hills, CA California 94022, US
Name:
BROWN, James E.Address:
Los Gatos, CA California 95032, US
Name:
LIN, WeiQiAddress:
Emerald Hills, VA Virginia 94062, US
Agent
Name:
Tego IP ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201361920617 PDate:
24.12.2013Country:
US
Classification
Categories:
A61K 31/568, A61K 31/575, A61K 31/56, A61P 43/00, A61P 1/16, A61K 35/12
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 26.1.2022
Expires: 22.12.2022
Payer: Tego IP ehf.
Number: 9
Paid: 15.1.2023
Expires: 22.12.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 15.12.2023
Expires: 22.12.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 15.12.2023
Expires: 22.12.2024
Payer: Árnason Faktor ehf.